GenScript Launched a 25% OFF Promotion for mAb Sequencing Service
Jul 02, 2010
PISCATAWAY, N.J., July 2nd, 2010- Internationally recognized biology contract research organization, GenScript USA Inc. has launched a seasonal promotion (25% discount) for monoclonal antibody sequencing service, which is scheduled to last until August 31st, 2010.
Antibody sequencing is a crucial component of antibody engineering. It may lead to new intellectual progress. Knowing the sequence of your monoclonal antibody is a fundamental step toward optimizing its functions. “GenScript has the ability to sequence most monoclonal antibodies and our service is geared to facilitate the development of a therapeutic candidate with enhanced properties, granting them with better potency, productivity, and antigenicity. It also helps to produce research antibodies configured with optimal constant regions.” says Dr. Frank Zhang, CEO of GenScript.
GenScript is capable of sequencing antibodies based on customer-selected specifications. The antibody sequencing service is ISO 9001 certified and can be applied to database banking and antibody therapeutics.
GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
# # # #
For further information, please contact:
Executive Vice President
GENSCRIPT USA Inc.
Your Innovation Partner in Drug Discovery!